It has long been acknowledged that there is little interaction between National Immunization Technical Advisory Groups (NITAGs) in the North and even less between those in the North and those in the South. Three international meetings of NITAGs recommended establishing an international network of NITAGs centred on a core functional structure and platform to facilitate future exchanges. The SIVAC Initiative (as part of a WHO Collaborating Center) followed-up with this recommendation, and launched an interactive platform involving all NITAGs worldwide in an active network and open collaboration: the NITAG Resource Center (NRC), accessible at http://www.nitag-resource.org. The NRC offers NITAG members and secretariats a centralized access to NITAG recommendations from around the world, systematic reviews, scientific publications, technical reports, updates from partners, and upcoming immunization events. A dedicated network manager will proactively update all contents through a strong network of regional and national focal points. The NRC is a first step towards a more fruitful and global collaboration between NITAGs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vaccine.2015.06.106 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vaccinating in Different Settings: Best Practices from Italian Regions.
Vaccines (Basel)
December 2024
Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy.
Background: The success of vaccination programs depends on a complex interplay of logistical, social, and structural factors. The objective of this study was to analyze the different approaches to vaccine administration implemented by several Italian regions since the onset of the SARS-CoV-2 pandemic.
Methods: After careful qualitative review of information gathered from scientific articles, official reports (grey literature), contact with regional health authorities, and local health departments, five vaccination strategies across several Italian regions focusing on alternative vaccine providers and/or settings were identified.
Systematic literature review of cost-effectiveness analyses of adult 15- and 20-valent pneumococcal vaccines.
Vaccine
February 2025
Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA; IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA. Electronic address:
Article Synopsis
- The review examined cost-effectiveness analyses of new adult pneumococcal vaccines (PCV15 and PCV20) across different countries.
- Most studies found that PCV20 offered cost savings or was more cost-effective than older vaccination strategies in high-income countries.
- Assumptions about vaccine effectiveness, duration of protection, and herd immunity effects varied, with most studies considered low-risk for bias.
How do national immunization technical advisory groups assess and use evidence: Findings from the SYSVAC survey.
Vaccine
January 2025
Robert Koch Institute, Immunization Unit, Berlin, Germany.
National immunization technical advisory groups (NITAGs) develop evidence-based vaccination recommendations. Systematic reviews (SRs) are important tools in that process, but conducting them is very resource-intensive. Given the considerable number of immunization-related SRs published and to minimize duplication of effort, a more practical approach for NITAGs is to use existing SRs.
View Article and Find Full Text PDFHealth Technology Assessment of Vaccines in Italy: History and Review of Applications.
Vaccines (Basel)
September 2024
Department of Medicine and Surgery, University of Perugia, 06123 Perugia, Italy.
Article Synopsis
- * A review of Italian vaccination documents highlights HTA's role in evaluating vaccines between 2012-2025 but shows a lack of independent funding for HTA reports.
- * Improved utilization of HTA is needed to ensure timely and evidence-based vaccine recommendations, filling gaps between research findings and policy decisions.
ATAGI targeted review 2023: Vaccination for preventing influenza in Australia.
Commun Dis Intell (2018)
July 2024
Australian Technical Advisory Group on Immunisation, Department of Health and Aged Care, Australian Government, Canberra, Australian Capital Territory, Australia.
Article Synopsis
- Annual influenza epidemics significantly impact global health and economy, but their activity dropped during the COVID-19 pandemic, only to resurge in Australia in early 2022, coinciding with the Omicron variant wave.
- * The current influenza vaccination program in Australia recommends yearly vaccinations for all individuals aged 6 months and older, with free vaccines provided for at-risk groups, but overall coverage, particularly among younger populations, remains low.
- * To improve vaccination rates, strategies such as better monitoring, culturally appropriate resources, and addressing specific population needs are essential for enhancing the overall effectiveness of the immunization program.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!